n.a. (SURG)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synergetics USA, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synergetics USA, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Synergetics USA, Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Valeant Pharmaceuticals International, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Synergetics USA, Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Valeant Pharmaceuticals International, Inc.

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Synergetics USA, Inc.

SYNERGETICS USA, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Valeant Pharmaceuticals International, Inc.

SYNERGETICS USA, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Valeant Pharmaceuticals International, Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Synergetics USA,...

Kendall Law Group Investigates Whether Synergetics USA, Inc. Acquisition By Valeant Pharmaceuticals International, Inc. Is In Best Interest Of Synergetics Shareholders

Kendall Law Group Investigates Whether Synergetics USA, Inc. Acquisition By Valeant Pharmaceuticals International, Inc. Is In Best Interest Of Synergetics Shareholders

Kendall Law Group, led by former federal judge Joe Kendall, is investigating Synergetics USA, Inc.

Synergetics USA (SURG) Stock Soars After Being Acquired by Valeant

Synergetics USA (SURG) Stock Soars After Being Acquired by Valeant

Synergetics USA (SURG) shares are spiking after the company was acquired by Valeant Pharmaceuticals (VRX) for $166 million today.

SYNERGETICS USA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Launches An Investigation Into The Proposed Sale Of Synergetics USA, Inc.; Encourages Investors To Contact The Firm For Additional Information

SYNERGETICS USA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Launches An Investigation Into The Proposed Sale Of Synergetics USA, Inc.; Encourages Investors To Contact The Firm For Additional Information

Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Synergetics USA, Inc.

Synergetics USA Enters Oversold Territory (SURG)

Synergetics USA Enters Oversold Territory (SURG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Why Synergetics (SURG) Stock Is Lower Today

Why Synergetics (SURG) Stock Is Lower Today

Synergetics (SURG) stock is on the decline after reporting lower profit for its third quarter.

Faruqi & Faruqi, LLP Launches An Investigation Against Synergetics USA, Inc. (SURG) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Faruqi & Faruqi, LLP Launches An Investigation Against Synergetics USA, Inc. (SURG) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc.

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Synergetics USA Inc. Stock Downgraded (SURG)

Synergetics USA Inc. Stock Downgraded (SURG)

Synergetics USA (Nasdaq:SURG) has been downgraded by TheStreet Ratings from from a buy to hold.

Synergetics USA To Present At Sidoti & Company Semi-Annual New York Micro Cap Conference

Synergetics USA To Present At Sidoti & Company Semi-Annual New York Micro Cap Conference

Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.

Synergetics Reports Record First Quarter

Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales, gross...

Synergetics USA To Strengthen Independent Board Representation

Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced that it plans to strengthen ...

Synergetics USA To Webcast Presentation At Stephens, Inc. Fall Investment Conference

Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.

A Solid Medical Name

This isn't a core holding, per se, but it is a nicely tradable vehicle at this juncture.

Synergetics USA Announces New Vitrectomy Products At American Academy Of Ophthalmology 2011 Annual Meeting

Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced two new ophthalmic products ...

Synergetics USA Inc. (SURG): Today's Featured Health Care Winner

Synergetics USA Inc was a winner within the health care sector, rising 5 cents (0.8%) to $6.11 on heavy volume.

10 Stocks to Watch: Synergetics, Joe's Jeans

Synergetic shares are plummeting in premarket trading after the company reported profit that was in line with expectations.

Synergetics Reports Fourth Quarter And Fiscal 2011 Results

Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported record sales and net...

6 Stocks Rising on Unusual Volume

Major moves in volume can signal unusual activity in stocks; here are six stocks rising on unusual volume today.

Synergetics USA Announces Preliminary Results For Fourth Quarter 2011 Including Record Sales And Net Income From Operations

Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures and markets innovative surgical instruments for ophthalmic and neurosurgical applications, today announced that it expects to...

Synergetics USA To Webcast Presentation At Craig-Hallum Capital Group 2nd Annual Alpha Select Conference

Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.

Synergetics USA, Inc. To Present At The Midwest IDEAS Investor Conference

Synergetics USA, Inc. (NASDAQ: SURG) announced today that the Company will present at the Midwest IDEAS Conference on Wednesday, August 31, 2011, at the University of Chicago’s Gleacher Center in ...

Synergetics USA, Inc. Elects D. Graeme Thomas And Patricia S. Williams To Board Of Directors

Synergetics USA, Inc. (NASDAQ: SURG) announced today that D.

Synergetics Reports Record Sales And Operating Income For Third Quarter

Synergetics USA, Inc. (NASDAQ: SURG) (“Synergetics” or the “Company”), a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and...

Synergetics USA, Inc. To Hold Investor Meetings With Craig-Hallum Capital Group

Synergetics USA, Inc. (NASDAQ: SURG) announced that the Company will meet with investors at Craig-Hallum Capital Group, LLC’s 8 th Annual Institutional Investor Conference in Minneapolis, Minnesota on Wednesday,...

Synergetics USA Announces Conference Call To Review Third Quarter Of Fiscal Year 2011 Results

Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call the morning of Wednesday, June 8, 2011, at 10:30 a.